Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
162 mg Aspirin for Preeclampsia Prevention
NCT05221164Phase 4Unknown
- Sponsor
- UnityPoint Health - Methodist
- Start
- Jul 2021
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aspirin in preeclampsia, sponsored by UnityPoint Health - Methodist. Primary endpoints: Number of participants with preeclampsia at 18 months and Number of participants with eclampsia. Status: unknown.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT05221164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05221164.